title: HIV testing, staging, and evaluation.
abstract: HIV testing and incidence are stable, but trends for certain populations are concerning. Primary prevention must be reinvigorated and target vulnerable populations. Science and policy have progressed to improve the accuracy, speed, privacy, and affordability of HIV testing. More potent and much better tolerated HIV treatments and a multidisciplinary approach to care have increased adherence and viral suppression. Changes to health care law in the United States seek to expand the affordability and access of improved HIV diagnostics and treatment. Continued challenges include improving long-term outcomes in people on lifetime regimens, reducing comorbidities associated with those regimens, and preventing further transmission.
authors.affiliation: Mid-Atlantic Permanente Research Institute, Kaiser Permanente, 2101 East Jefferson Street, 6 West, Rockville, MD 20852, USA. Electronic address: carla.v.rodriguez@kp.org.
authors.forename: Carla V
authors.initials: CV
authors.lastname: Rodriguez
authors.affiliation: HIV/AIDS, Mid-Atlantic Permanente Research Institute, Kaiser Permanente, 2101 East Jefferson Street, 6 West, Rockville, MD 20852, USA.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Horberg
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control; D006291:Health Policy / Q000639:trends; D006297:Health Services Accessibility; D006801:Humans; D014481:United States
chemical_list: D044966:Anti-Retroviral Agents
keywords: HIV epidemiology; HIV surveillance